The significant downregulation of CDC25C post-C/T in Late Recurrence patients but not in Early Recurrence patients suggests that HGSOC patients in whom C/T induces cell cycle arrest are more likely to experience delayed recurrence of cancer, as one would expect. This evidence concerns the gene CDC25C and cancer.